News and Events

Needle-free technology, originally developed at the AIBN, has been used to administer a COVID-19 vaccine candidate to successfully protect mice, demonstrating the potential of non-invasive delivery.

A pilot facility at AIBN could be producing mRNA vaccines and cancer therapies for research and development within months after receiving backing from the Australian Government.

Faster-charging and more sustainable batteries with a life up to three times greater than lithium ion are being built with technology developed at AIBN.

University of Queensland scientists have published the clinical trial data confirming their molecular clamp-stabilised vaccine technology was safe and potentially effective.

On International Womens’ Day, we asked AIBN’s Dr Nasim Amiralian what advice she would give to her 16-year-old self, if she could mentor a younger Nasim.